HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful treatment with weekly paclitaxel in a patient with recurrent endometrial cancer. A case report.

Abstract
The best treatment for recurrent endometrial cancer is still uncertain, although weekly paclitaxel has shown some promise in the management of this disease. In this report we present a patient with recurrent endometrial cancer treated with weekly paclitaxel. Serial power Doppler angiography was used to assess the effects of therapy. The response was good, suggesting that recurrent endometrial cancer may be successfully treated with weekly paclitaxel and effectively monitored with power Doppler angiography.
AuthorsS J Chang, T C Chen, T Y Wang, C Y Hsu, H S Chen, Y C Yang
JournalEuropean journal of gynaecological oncology (Eur J Gynaecol Oncol) Vol. 24 Issue 5 Pg. 377-8 ( 2003) ISSN: 0392-2936 [Print] Singapore
PMID14584648 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Paclitaxel
Topics
  • Adenocarcinoma (diagnostic imaging, drug therapy, secondary)
  • Adult
  • Antineoplastic Agents, Phytogenic (administration & dosage)
  • Drug Administration Schedule
  • Endometrial Neoplasms (diagnostic imaging, pathology)
  • Female
  • Humans
  • Paclitaxel (administration & dosage)
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: